China Biologic Eligible for Provincial R&D Financial Support

China Biologic Products, which has been rolling up plasma-based companies in China, said its Shandong Taibang Biological Products subsidiary was named one of twelve model Shandong-based biopharmaceutical companies. The honor, which was conferred by the Shandong provincial government, makes Shandong Taibang eligible for financial subsidies and tax concessions to support new drug R&D. More details... Stock Symbol: (NSDQ: CBPO)